Tags

Type your tag names separated by a space and hit enter

Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report.
Am J Otolaryngol. 2011 Nov-Dec; 32(6):620-3.AJ

Abstract

Sebaceous gland carcinoma (SGC) of the eyelid is a highly malignant neoplasm that arises from the meibomian glands, glands of Zeis, and sebaceous glands of the skin. The characteristics of this disease are high recurrence rate, significant metastatic potential, and notable mortality rate, which are quite different from basal cell carcinoma (BCC). We report the case of a 37-year-old woman with the history of left lower eyelid BCC (diagnosed 9 years ago), who had left parotid lymph nodes metastases and local recurrence twice. The chief complaint during visit was a left upper eyelid swelling mass noted for 3 months. She received salvage ablation surgery later. The final pathologic report is SGC. The diagnosis corresponds to the clinical presentation of this patient at last. The delay between initial examination and final diagnosis in this patient is about 9 years, but operation and concurrent chemotherapy and radiotherapy were performed after left parotid lymph nodes metastasis was noted. Although there was still local recurrence after concurrent chemotherapy and radiotherapy, the patient is still alive without distant metastasis. In this article, we would discuss the differences of the pathologic characters, treatment, and prognosis between SGC and BCC.

Authors+Show Affiliations

Department of Otolaryngology-Head and Neck Surgery, Mackay Memorial Hospital, Taipei, Taiwan.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

21168242

Citation

Kan, Li-Wei, et al. "Recurrent Sebaceous Gland Carcinoma of Eyelid Previously Diagnosed as Basal Cell Carcinoma: Case Report." American Journal of Otolaryngology, vol. 32, no. 6, 2011, pp. 620-3.
Kan LW, Leu YS, Tzen CY, et al. Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report. Am J Otolaryngol. 2011;32(6):620-3.
Kan, L. W., Leu, Y. S., Tzen, C. Y., & Wu, C. H. (2011). Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report. American Journal of Otolaryngology, 32(6), 620-3. https://doi.org/10.1016/j.amjoto.2010.10.001
Kan LW, et al. Recurrent Sebaceous Gland Carcinoma of Eyelid Previously Diagnosed as Basal Cell Carcinoma: Case Report. Am J Otolaryngol. 2011 Nov-Dec;32(6):620-3. PubMed PMID: 21168242.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report. AU - Kan,Li-Wei, AU - Leu,Yi-Shing, AU - Tzen,Chi-Yuan, AU - Wu,Chien-Hsiu, Y1 - 2010/12/18/ PY - 2010/08/11/received PY - 2010/09/20/revised PY - 2010/10/06/accepted PY - 2010/12/21/entrez PY - 2010/12/21/pubmed PY - 2012/3/23/medline SP - 620 EP - 3 JF - American journal of otolaryngology JO - Am J Otolaryngol VL - 32 IS - 6 N2 - Sebaceous gland carcinoma (SGC) of the eyelid is a highly malignant neoplasm that arises from the meibomian glands, glands of Zeis, and sebaceous glands of the skin. The characteristics of this disease are high recurrence rate, significant metastatic potential, and notable mortality rate, which are quite different from basal cell carcinoma (BCC). We report the case of a 37-year-old woman with the history of left lower eyelid BCC (diagnosed 9 years ago), who had left parotid lymph nodes metastases and local recurrence twice. The chief complaint during visit was a left upper eyelid swelling mass noted for 3 months. She received salvage ablation surgery later. The final pathologic report is SGC. The diagnosis corresponds to the clinical presentation of this patient at last. The delay between initial examination and final diagnosis in this patient is about 9 years, but operation and concurrent chemotherapy and radiotherapy were performed after left parotid lymph nodes metastasis was noted. Although there was still local recurrence after concurrent chemotherapy and radiotherapy, the patient is still alive without distant metastasis. In this article, we would discuss the differences of the pathologic characters, treatment, and prognosis between SGC and BCC. SN - 1532-818X UR - https://www.unboundmedicine.com/medline/citation/21168242/Recurrent_sebaceous_gland_carcinoma_of_eyelid_previously_diagnosed_as_basal_cell_carcinoma:_case_report_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0196-0709(10)00198-5 DB - PRIME DP - Unbound Medicine ER -